Concern with antidepressant withdrawal or “discontinuation syndrome” seems to be intensifying in the professional literature as more and more evidence accumulates about the risks of taking, and then stopping their use. In addition, both clinicians and patients may incorrectly attribute discontinuation symptoms to a relapse of the underlying psychiatric illness for which the SSRI was prescribed, or to another psychiatric or medical condition.